Related Experiment Video
Updated: Jun 21, 2026

09:38
Generalized Psychophysiological Interaction (PPI) Analysis of Memory Related Connectivity in Individuals at Genetic Risk for Alzheimer's Disease
Published on: November 14, 2017
Significant negative correlations between capillary expressed eNOS and Alzheimer lesion burden
1Faculty of Applied Health Sciences, Brock University, St. Catharine's, Ontario, Canada. bjeynes@brocku.ca
Neuroscience Letters
|August 8, 2009
Summary
Endothelial nitric oxide synthase (eNOS) activity shows a negative correlation with neurofibrillary tangles and senile plaques in Alzheimer
Area of Science:
- Neuroscience
- Biochemistry
- Pathology
Background:
- Nitric oxide (NO) plays crucial roles in the central nervous system (CNS), including vasoregulation and neuroprotection.
- Dysregulation of NO levels is implicated in neurodegenerative diseases like Alzheimer's disease (AD).
- Nitrogen oxide synthase (NOS) isoforms (eNOS, iNOS, nNOS) produce NO, and their roles in AD are under investigation.
Purpose of the Study:
- To investigate the correlation between NOS isoform-positive capillaries and neuropathological hallmarks in Alzheimer's disease.
- To compare these correlations in temporal and calcarine cortices between AD and control brains.
Main Methods:
- Immunohistochemistry was used to stain brain sections for tau protein, beta-amyloid, and NOS isoforms (eNOS, iNOS, nNOS).
- Quantification of neurofibrillary tangles (NFTs), senile plaques (SPs), and NOS-positive capillaries in cortical samples.
- Non-parametric statistical analyses were applied to compare AD and control groups.
Main Results:
- A significant negative correlation was observed between eNOS-positive capillaries and the presence of NFTs and SPs in both temporal and calcarine cortices of AD brains.
- No significant correlations were found for iNOS or nNOS positive capillaries with NFTs and SPs.
- These findings suggest a protective role for eNOS in the context of AD neuropathology.
Conclusions:
- Endothelial nitric oxide synthase (eNOS) activity may be inversely associated with the development of key Alzheimer's disease pathologies.
- Targeting eNOS activity or NO production pathways could represent a potential therapeutic strategy for AD.
- Further research into NO regulation in AD is warranted.
More Related Videos
Related Concept Videos
Alzheimer Disease ll: Pathophysiology
Alzheimer disease involves structural changes in the brain that begin long before symptoms appear. The most distinctive features are extracellular neuritic plaques and intracellular neurofibrillary tangles.Neuritic plaques form in the cerebral cortex and around blood vessels. These plaques contain a dense core of beta-amyloid (Aβ)—a toxic protein fragment that clumps outside neurons. The core is surrounded by damaged neuronal extensions, as well as reactive astrocytes and microglia. Abnormal...
Alzheimer Disease l: Introduction
Alzheimer disease is a chronic, progressive, and irreversible neurodegenerative disorder and the most common cause of dementia in older adults. It leads to gradual neuronal loss, causing cognitive decline, behavioral changes, and loss of functional independence.Risk Factors and EtiologyThe disease is multifactorial. Age is the strongest risk factor, with prevalence doubling every 5 years after age 65. Genetic factors include mutations in genes such as APP, PSEN1, and PSEN2, which are associated...
Neural Regulation
Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.
Alzheimer's Disease: Overview
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ and tau...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ and tau...
Dementia l: Introduction
Dementia is an acquired, progressive syndrome characterized by a decline in multiple cognitive domains severe enough to impair daily functioning and reduce independence. Although memory loss is a central feature, the diagnosis requires additional deficits involving language, executive function, visuospatial skills, judgment, calculation, or abstract reasoning. These cognitive impairments reflect underlying neurodegenerative or vascular processes that gradually disrupt neuronal networks...

